Indi Molecular Employee Directory
Biotechnology ResearchCalifornia, United States2-10 Employees
Indi Molecular operates in the biotechnology research sector, developing protein catalyzed capture (PCC) agents as a small synthetic molecule alternative to antibody-based therapeutics. These agents are positioned to serve dual roles: as targeted therapeutics and as diagnostic tools for in vivo imaging, enabling precision PET imaging and potentially guiding cancer immunotherapy. The technology aims to allow specific delivery to diseased cells and to align diagnostic and therapeutic capabilities through related chelation chemistry, supporting oncological applications. The company is based in Culver City, California, and focuses on enabling both diagnostic and therapeutic workflows within oncology. Since its inception in 2013, Indi Molecular has pursued collaborations in the imaging space, including a notable partnership with GE Healthcare to develop immune cell–targeted PET tracers for cancer treatment guidance.